4//SEC Filing
Cohen Joshua B 4
Accession 0000950170-24-106915
CIK 0001658551other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:39 PM ET
Size
6.5 KB
Accession
0000950170-24-106915
Insider Transaction Report
Form 4
Cohen Joshua B
DirectorCo-Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-12$1.57/sh+34,449$54,085→ 3,237,301 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-12−34,449→ 1,857 totalExercise: $1.57Exp: 2025-02-26→ Common Stock (34,449 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001898644
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:39 PM ET
- Size
- 6.5 KB